MLG Wealth Management DBA Pine Grove Financial Group Raises Holdings in UnitedHealth Group Incorporated $UNH

MLG Wealth Management DBA Pine Grove Financial Group raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,231 shares of the healthcare conglomerate’s stock after buying an additional 1,284 shares during the quarter. MLG Wealth Management DBA Pine Grove Financial Group’s holdings in UnitedHealth Group were worth $3,006,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. Sarver Vrooman Wealth Advisors bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $25,000. Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $27,000. Lifetime Wealth Management P.C. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $29,000. Wilkerson Advisory Group LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Aberdeen Wealth Management LLC purchased a new position in UnitedHealth Group during the second quarter worth $31,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $396.79 on Tuesday. The stock has a market capitalization of $356.15 billion, a PE ratio of 25.53, a PEG ratio of 1.49 and a beta of 0.61. The company has a 50 day moving average price of $411.20 and a 200-day moving average price of $365.42. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same quarter last year, the firm earned $4.08 EPS. The business’s revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s payout ratio is 59.72%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on UNH. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, September 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Mizuho raised their price target on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. Barclays upped their price objective on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $456.56.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.19% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.